Funding, launches and regulatory moves across the neurotech startup map.
Subscribed. Check your inbox to confirm.
•
Neurofounders Insights
$ Funding -
Series B
MODALITY
Biomarkers
FORM FACTOR
Software/app
INTERFACE DEPTH
Software
INDICATION
Psychiatry
TARGET USER
Clinicians
REGULATORY STAGE
FDA cleared (510k)
GrayMatters Health is positioned in neurofeedback therapeutics, with FDA-cleared software targeting PTSD and depression through brain network self-regulation. Its clinical validation differentiates it from wellness-focused neurofeedback platforms.
.jpeg)
.svg)
